John Parkinson
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$5.4MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $5.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 6, 2026 | NIH | SBIR Phase II Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer | $271K | Thetis Pharmaceuticals LLC |
| Sep 8, 2025 | NIH | SBIR Phase II Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer | $1.7M | Thetis Pharmaceuticals LLC |
| Apr 16, 2025 | NIH | SBIR Phase II Development of TP-317 in Ulcerative Colitis | $1000K | Thetis Pharmaceuticals LLC |
| Mar 14, 2024 | NIH | SBIR Phase II Development of TP-317 in Ulcerative Colitis | $1000K | Thetis Pharmaceuticals LLC |
| Jun 2, 2023 | NIH | SBIR Phase II Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer | $398K | Thetis Pharmaceuticals LLC |
| Mar 15, 2023 | NIH | SBIR Phase II Development of TP-317 in Ulcerative Colitis | $998K | Thetis Pharmaceuticals LLC |
Peer ranks
Federal funding#241
Awards as PI#315
Patents#273
Companies
- Thetis Pharmaceuticals LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.